You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory to standard therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pneumonia, Pneumocystis Carinii, HIV Trial in West Columbia (Trimetrexate glucuronate, Methylprednisolone, Pentamidine

Terminated
  • Pneumonia, Pneumocystis Carinii
  • HIV Infections
  • Trimetrexate glucuronate
  • +4 more
  • West Columbia, South Carolina
    Julio Arroyo
Oct 27, 2021

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Aberdeen, United Kingdom
  • +24 more
Apr 28, 2023

Fecal Microbiota Alterations in Steroid Refractory Active

Completed
  • Colitis, Ulcerative
  • Graz, Styria, Austria
    LKH Graz
Sep 7, 2021

Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

Recruiting
  • Platinum-Refractory Fallopian Tube Carcinoma
  • +11 more
  • Copanlisib Hydrochloride
  • +4 more
  • Aurora, Colorado
  • +2 more
Dec 8, 2022

Gout Trial in United States (SAP001)

Recruiting
  • Gout
  • San Diego, California
  • +8 more
Jan 9, 2023

Leukemia, Myeloid, Acute Trial in United States (Liposomal Annamycin)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • Liposomal Annamycin
  • La Jolla, California
  • +3 more
Feb 28, 2022

Pelvic Radiation Therapy, Radiation-induced Hemorrhagic Cystitis Trial in Paris (Mesenchymal Stromal Cell (MSC) injections)

Recruiting
  • Pelvic Radiation Therapy
  • Radiation-induced Hemorrhagic Cystitis
  • Mesenchymal Stromal Cell (MSC) injections
  • Paris, France
    Hématologie et thérapie cellulaire, Hôpital Saint Antoine
Jul 31, 2021

Solid Tumors Trial in Seoul (YYB101)

Completed
  • Solid Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 12, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (Bortezomib, Dexamethasone, Pelareorep)

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
  • +1 more
Aug 19, 2022

AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

Not yet recruiting
  • AML, Adult
  • Pharmacoscopy
  • Clinical standard-of-care (physician's choice)
  • (no location specified)
Nov 20, 2023

Solid Tumor Trial in United States (STP707)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +3 more
Jan 27, 2022

Tumor, Solid, Gall Bladder Cancer, Cervical Cancer Trial in Santiago, Vina del Mar (Andes-1537 for Injection)

Completed
  • Tumor, Solid
  • +5 more
  • Andes-1537 for Injection
  • Santiago, Region Metropolitana, Chile
  • +3 more
Feb 23, 2022

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy Trial in China (APG-2575, reduced-dose HHT, standard-dose HHT)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukaemia
  • Myeloid Malignancy
  • Beijing, Beijing, China
  • +9 more
Jan 10, 2022

Tumor Metastasis Trial run by the NHLBI (methotrexate, Cyclosporin)

Terminated
Has Results
  • Neoplasm Metastasis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 8, 2021

Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma

Not yet recruiting
  • Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +45 more
  • Internet-Based Intervention
  • +2 more
  • Manhasset, New York
  • +3 more
Mar 30, 2022

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Leukemia Trial in Houston (MEK 162)

Terminated
Has Results
  • Leukemia
  • MEK 162
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2021

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)

Not yet recruiting
  • Follicular Lymphoma
  • Axicabtagene Ciloleucel
  • +5 more
  • (no location specified)
Sep 21, 2023

Learn About Medicine in People With Relapsed Refractory Multiple

Completed
  • Multiple Myeloma
  • New York, New York
    Pfizer
Nov 14, 2022

Thalassemia Major Trial in New York, Bangkok, Chiang Mai (DST-0509, Jadenu, Exjade)

Completed
  • Thalassemia Major
  • New York, New York
  • +3 more
Jan 31, 2022

Refractory Mycosis Fungoides Trial in Scottsdale (drug, other, radiation)

Completed
  • Refractory Mycosis Fungoides
  • Aminolevulinic Acid Hydrochloride
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 3, 2023

Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

Not yet recruiting
  • Lymphoma, B-Cell
  • +7 more
  • Adaptive Bridging Radiation Therapy (ABRT)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 16, 2023

Chronic Cervical Radiculopathy Trial (radiofrequency ablation)

Not yet recruiting
  • Chronic Cervical Radiculopathy
  • radiofrequency ablation
  • (no location specified)
Feb 18, 2023